Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

NCT06290427 · Azienda Ospedaliera Universitaria Integrata Verona · Updated 3 Jan 2025

What is being tested
DaVinci RAPN; Hugo RAS RAPN
For
Renal Carcinoma
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 90 years. About 30 people. The full rules are on the registry page.
Where
Italy
When
Starts or started 1 Feb 2024, ends June 2025. Registered 4 March 2024.
Results
None posted yet.

In the researchers' words

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: * DaVinci®; * Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to join one of these two experimental group: 1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.
ClinicalTrials.gov, NCT06290427

Sites

  • Urology Unit, AOUI VeronaVerona, VR, Italy